Publications by authors named "D Valsamidis"
Background/aim: Hysterectomy is the most frequent gynecological surgery. Vaginal hysterectomy (VH) seems to be related to favorable perioperative outcomes compared to abdominal or laparoscopic approaches. As the population ages, anesthesia that is safer for the elderly, such as local anesthesia (LA) with conscious sedation, is gaining popularity and is related to favorable outcomes in patients' recovery compared to general or regional anesthesia.
View Article and Find Full Text PDFArticle Synopsis
- The study evaluates the effectiveness of two different concentrations of ropivacaine (0.1% and 0.2%) used in programmed intermittent epidural boluses (PIEBs) for pain management during labor.
- Both regimens provided satisfactory pain relief without causing motor blockade, but the 0.2% ropivacaine concentration resulted in greater pain relief and higher patient satisfaction.
- The 0.2% group also had lower diastolic blood pressure and APGAR scores for newborns, while overall anesthetic consumption was similar across both groups.
Agenesis of inferior vena cava in pregnancy: A case report and narrative review.
Eur J Obstet Gynecol Reprod Biol
August 2024
Agenesis of inferior vena cava (AIVC) is an extremely rare congenital abnormality. In AIVC, venous flow from the lower extremities enter superior vena cava mainly through the azygous and hemiazygous system, forming anastomotic collateral vessels. A global increase in intra-abdominal pressure by the gravid uterus may further stress the collateral system, increase venous stasis and decrease venous return.
View Article and Find Full Text PDFMcCune-Albright syndrome: Anesthetic management of cesarean section.
Int J Obstet Anesth
February 2024
Objective: To evaluate the safety and the effectiveness of thoracic epidural analgesia as part of the enhanced recovery after surgery (ERAS) multimodal analgesic protocol in patients with gynecologic oncology who have undergone laparotomy for suspected or confirmed malignancy.
Methods: We conducted a prospective cohort study, following an enhanced recovery after surgery pathway, among patients who had undergone laparotomy for confirmed or suspected gynecological malignancy between January 2020 and September 2021. All patients who underwent laparotomy at the gynecologic oncology department for the aforementioned reason during that time were considered eligible.